EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prevalence of Pretreatment Drug Resistance and Transmission Networks Among Newly Diagnosed HIV-1-Infected Individuals in Nanning, Guangxi, China

Qiuqian Su, Yanjun Li, Ting Huang, Liangjia Wei, Jinfeng He, Yumei Huang, Guidan Mo, Jiao Qin, Chunxing Tao, Xinju Huang, Li Ye iD, Hao Liang iD und 2 weitere

Pathogens · 31.03.2025 · 14 (4) · 336

DOI: 10.3390/pathogens14040336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 31.03.2025. Verfasst von Qiuqian Su und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Drug Resistance, Viral, Anti-HIV Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangxi Youth Foundation, Guangxi Bagui Young Top Scholar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The scale-up of antiretroviral therapy (ART) has markedly increased pretreatment drug resistance (PDR) among newly diagnosed HIV-infected individuals. This study aims to assess the prevalence and characteristics of PDR, infer the genetic transmission network, and evaluate the effect of PDR on ART in Nanning City, Guangxi.

Methods

This study was conducted in the Fourth People’s Hospital of Nanning from 2019 to 2023. PDR was estimated using the Stanford algorithm. Genetic transmission networks were inferred by HIV-TRACE and visualized with Cytoscape. Logistic regression identified PDR-related factors. The Cox proportional hazards model assessed the impact of drug resistance on virological and immunological failure. Among 234 participants, the prevalence of PDR was 8.97%. CRF07_BC (35.9%), CRF-01AE (27.35%), and CRF08_BC (23.9%) were the top three HIV-1 strains. Resistance to non-nucleoside reverse-transcriptase inhibitors, protease inhibitors, nucleoside reverse-transcriptase inhibitors, and integrase strand-transfer inhibitors was 4.27%, 2.56%, 1.28%, and 0.43%, respectively. Overall, 21.37% of the participants exhibited drug resistance mutations (DRMs). Homosexuals were less likely to have PDR compared to heterosexuals ([aOR] 0.09, 95% CI 0.01–0.86). In the genetic network, V179D/E was also the most frequent DRM. Additionally, the incidence of virological failure (19.23%) and immune failure (20.09%) after one year of treatment did not show significant differences in different drug resistance groups.

Conclusions

The prevalence of PDR in Nanning City is moderate, driven largely by the V179D and K103N mutations. The cross-transmission networks emphasize the imperative of PDR testing and targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV-1Drug Resistance, ViralAnti-HIV AgentsHumansChinaMaleFemalePrevalenceAdultMiddle AgedYoung AdultMutation

Stichwörter der Autor:innen

HIV/AIDSdrug mutationmolecular epidemiologypretreatment HIV-drug resistancetransmission networks

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning 530021, China.
  • School of Public Health, Guangxi Medical University, Nanning 530021, China.
  • The Fourth People's Hospital of Nanning, Nanning 530023, China.
  • Biosafety III Laboratory, Life Science Institute, Guangxi Medical University, Nanning 530021, China.
  • Department of Clinical Research, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

ORCID-Profile: Li Ye, Hao Liang

Förderung

  • National Natural Science Foundation of China
  • Guangxi Youth Foundation
  • Guangxi Bagui Young Top Scholar
  • China scholar council
  • Guangxi Zhuang Autonomous Region Health Commission, Self-Funded Research Project

Zitieren

APA

Su, Q., Li, Y., Huang, T., Wei, L., He, J., Huang, Y., Mo, G., Qin, J., Tao, C., Huang, X., Ye, L., Liang, H., Liang, B., & Huang, J. (2025). The Prevalence of Pretreatment Drug Resistance and Transmission Networks Among Newly Diagnosed HIV-1-Infected Individuals in Nanning, Guangxi, China. Pathogens, 14(4), 336. https://doi.org/10.3390/pathogens14040336

Vancouver

Su Q, Li Y, Huang T, Wei L, He J, Huang Y, et al. The Prevalence of Pretreatment Drug Resistance and Transmission Networks Among Newly Diagnosed HIV-1-Infected Individuals in Nanning, Guangxi, China. Pathogens. 2025;14(4):336. doi:10.3390/pathogens14040336

BibTeX
@article{Su2025,
  author = {Su, Qiuqian and Li, Yanjun and Huang, Ting and Wei, Liangjia and He, Jinfeng and Huang, Yumei and Mo, Guidan and Qin, Jiao and Tao, Chunxing and Huang, Xinju and Ye, Li and Liang, Hao and Liang, Bingyu and Huang, Jinping},
  title = {The Prevalence of Pretreatment Drug Resistance and Transmission Networks Among Newly Diagnosed HIV-1-Infected Individuals in Nanning, Guangxi, China},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {336},
  doi = {10.3390/pathogens14040336}
}
Kostenlos starten →